These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes. Campistol JM, Torregrosa JV, Ponz E, Fenollosa B. Contrib Nephrol; 1999; 125():76-85. PubMed ID: 9895432 [No Abstract] [Full Text] [Related]
3. Structural and functional characteristics of currently available PMMA dialyzers. Ghezzi PM, Meinero S, Ronco C. Contrib Nephrol; 1999; 125():25-40. PubMed ID: 9895428 [No Abstract] [Full Text] [Related]
4. Behaviour of clearances and diffusive permeability during hemodialysis with PMMA dialyzers: clinical study. Ghezzi PM, Canepari G, Ronco C. Contrib Nephrol; 1999; 125():53-64. PubMed ID: 9895430 [No Abstract] [Full Text] [Related]
5. Biocompatibility of PMMA membranes in acute and chronic patients with renal failure. Manzoni C, Locatelli F. Contrib Nephrol; 1999; 125():65-75. PubMed ID: 9895431 [No Abstract] [Full Text] [Related]
6. Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes. Buoncristiani U, Galli F, Benedetti S, Errico R, Beninati S, Ghibelli L, Floridi A, Canestrari F. Contrib Nephrol; 1999; 125():133-58. PubMed ID: 9895437 [No Abstract] [Full Text] [Related]
7. Efficiency parameters and treatment adequacy of hemodialysis and hemodiafiltration using polymethylmethacrylate membranes. Di Filippo S, Manzoni C, Locatelli F. Contrib Nephrol; 1999; 125():86-95. PubMed ID: 9895433 [No Abstract] [Full Text] [Related]
8. Clinical experience with PMMA membrane. Albertazzi A, Bonomini M. Contrib Nephrol; 1999; 125():213-21. PubMed ID: 9895443 [No Abstract] [Full Text] [Related]
9. Pyrogen transfer across PMMA membranes. Cappelli G, Ballestri M, Di Felice A, Bonucchi D, Albertazzi A. Contrib Nephrol; 1999; 125():233-9. PubMed ID: 9895445 [No Abstract] [Full Text] [Related]
10. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes. Floege J, Koch KM. Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985 [No Abstract] [Full Text] [Related]
11. Nitric oxide production with PMMA membrane. Amore A, Coppo R. Contrib Nephrol; 1999 Jul; 125():182-96. PubMed ID: 9895440 [No Abstract] [Full Text] [Related]
12. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy]. Czyz W, Szepietowski T. Postepy Hig Med Dosw; 1992 Jul; 46(2):209-38. PubMed ID: 1470582 [Abstract] [Full Text] [Related]
13. Identification of an erythropoietic inhibitor from the dialysate collected in the hemodialysis with PMMA membrane (BK-F). Yamada S, Kataoka H, Kobayashi H, Ono T, Minakuchi J, Kawano Y. Contrib Nephrol; 1999 Jul; 125():159-72. PubMed ID: 9895438 [No Abstract] [Full Text] [Related]
14. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study. Traut M, Haufe CC, Eismann U, Deppisch RM, Stein G, Wolf G. Blood Purif; 2007 Jul; 25(5-6):432-40. PubMed ID: 17957097 [Abstract] [Full Text] [Related]
15. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P. Nephrol Dial Transplant; 2000 Jul; 15 Suppl 1():49-54. PubMed ID: 10737167 [Abstract] [Full Text] [Related]
16. Beta2-microglobulin and low-flux synthetic dialyzers. Klinkmann H, Buscaroli A, Stefoni S. Artif Organs; 1998 Jul; 22(7):585-90. PubMed ID: 9684696 [Abstract] [Full Text] [Related]